Conversely, when oncogenic KRAS signaling is accompanied by genetic inactivation of CIC, the complete lack of CIC-mediated repression would allow tumor initiation without KRAS allelic imbalances (Appendix Fig. S5). The gene discussed is KRAS; the disease is neoplasm.